Linear peptides derived from the HIV gp41 C-terminus (C-peptides), such as the 36-residue Fuzeon, are potent HIV fusion inhibitors. 1 These molecules bind to the N-peptide region of gp41 and act as dominant negative inhibitors of an intramolecular protein-protein interaction that powers fusion of the viral and host cell membranes. [2] [3] [4] The gp41 N-peptide region contains a surface pocket [3] [4] [5] that is less prone to mutation than other gp41 regions or HIV enzymes. 6 This pocket is occupied in the post-fusion state by three R-helical residues found near the gp41 C-terminus: Trp628, Trp631, and Ile635; together, these residues comprise the WWI epitope. 3-5 Simple 7,8 and constrained 9,10 R-peptides, aromatic foldamers, 11 peptide-small molecule conjugates, 12 and small molecules 13 that bind this pocket inhibit gp41-mediated fusion. Here, we describe a set of 3 -decapeptides, WWI-1-4, in which the WWI epitope is presented on one face of a short 14-helix ( Figure  1 ). 14 WWI-1-4 bind to a validated gp41 model in Vitro and inhibit gp41-mediated fusion in cell culture. Our work suggests that -peptide 14-helices, which are likely to be metabolically stable and protease resistant, [15] [16] [17] can function as in ViVo inhibitors of intramolecular protein-protein interactions. 18 We synthesized 19 four 3 -peptides ( WWI-1-4) containing the WWI epitope in both possible orientations on each available face of a 3 -decapeptide 14 possessing significant 14-helix stability in aqueous solution due to electrostatic macrodipole stabilization 20 and side chain-side chain salt bridges. 21, 22 We also prepared WAI-1 as a control, as previous work has documented the significant contribution of the central Trp631 to gp41 affinity and viral infectivity. 7 The circular dichroism spectra of WWI-1-4 and WAI-1 all display the expected minima at 214 nm ( Figure  2A ). 14, 20, 23 The spectra of WWI-1-4, but not WAI-1, also show a transition at 227 nm, which may result from distortions in the 14-helix or the presence of two tryptophan residues in close proximity. 24 Two-dimensional NMR spectroscopy in CD 3 OH confirmed the presence of 14-helix structure in WWI-1; NOESY spectra showed five of seven possible C R (i) f C (i+3) NOEs and three of six possible (C N (i) f C (i+3) NOEs. No NOEs inconsistent with 14-helical structure were observed. 19 Each -peptide was fluorescently labeled 19 at the N-terminus and used in direct fluorescence polarization (FP) experiments to determine its affinity for the gp41 model IZN17. 25 IZN17, which exists as a stable trimer in solution, 25 contains 24 residues of an isoleucine zipper 26 fused in register to 17 residues from gp41 containing the pocket for the WWI epitope. 25 All four -peptides, WWI-1-4 Flu , bound IZN17 well, with equilibrium affinities of 0.75 ( 0.1, 1.0 ( 0.3, 2.4 ( 0.7, and 1.5 ( 0.4 µM, respectively ( Figure 2B ). Interestingly, in this case, IZN17 affinity is relatively insensitive to the orientation of the WWI epitope relative to either the 14-helix macrodipole or the salt-bridging face. 14 The affinity of WWI-1-4 for IZN17 is nearly identical to that of the highest affinity R-peptide of comparable size (K d ) 1.2 µM). 10 Also, WWI-1 binds IZN17 with significantly higher affinity than it binds carbonic anhydrase II (K d g 115 µM) or calmodulin (K d > 100 µM), two globular proteins that recognize hydrophobic and/or helical molecules. 19 Two experiments were performed to investigate the binding mode of WWI-1-4. 27 These data suggest that the affinity of WWI-1-4 for IZN17 results from interactions between the WWI epitope and the targeted IZN17 pocket.
Linear peptides derived from the HIV gp41 C-terminus (C-peptides), such as the 36-residue Fuzeon, are potent HIV fusion inhibitors. 1 These molecules bind to the N-peptide region of gp41 and act as dominant negative inhibitors of an intramolecular protein-protein interaction that powers fusion of the viral and host cell membranes. [2] [3] [4] The gp41 N-peptide region contains a surface pocket [3] [4] [5] that is less prone to mutation than other gp41 regions or HIV enzymes. 6 This pocket is occupied in the post-fusion state by three R-helical residues found near the gp41 C-terminus: Trp628, Trp631, and Ile635; together, these residues comprise the WWI epitope. [3] [4] [5] Simple 7,8 and constrained 9,10 R-peptides, aromatic foldamers, 11 peptide-small molecule conjugates, 12 and small molecules 13 that bind this pocket inhibit gp41-mediated fusion. Here, we describe a set of 3 -decapeptides, WWI-1-4, in which the WWI epitope is presented on one face of a short 14-helix ( Figure  1 ). 14 WWI-1-4 bind to a validated gp41 model in Vitro and inhibit gp41-mediated fusion in cell culture. Our work suggests that -peptide 14-helices, which are likely to be metabolically stable and protease resistant, [15] [16] [17] can function as in ViVo inhibitors of intramolecular protein-protein interactions. 18 We synthesized 19 four 3 -peptides ( WWI-1-4) containing the WWI epitope in both possible orientations on each available face of a 3 -decapeptide 14 possessing significant 14-helix stability in aqueous solution due to electrostatic macrodipole stabilization 20 and side chain-side chain salt bridges. 21, 22 We also prepared WAI-1 as a control, as previous work has documented the significant contribution of the central Trp631 to gp41 affinity and viral infectivity. 7 The circular dichroism spectra of WWI-1-4 and WAI-1 all display the expected minima at 214 nm ( Figure  2A ). 14, 20, 23 The spectra of WWI-1-4, but not WAI-1, also show a transition at 227 nm, which may result from distortions in the 14-helix or the presence of two tryptophan residues in close proximity. 24 Two-dimensional NMR spectroscopy in CD 3 OH confirmed the presence of 14-helix structure in WWI-1; NOESY spectra showed five of seven possible C R (i) f C (i+3) NOEs and three of six possible (C N (i) f C (i+3) NOEs. No NOEs inconsistent with 14-helical structure were observed. 19 Each -peptide was fluorescently labeled 19 at the N-terminus and used in direct fluorescence polarization (FP) experiments to determine its affinity for the gp41 model IZN17. 25 IZN17, which exists as a stable trimer in solution, 25 contains 24 residues of an isoleucine zipper 26 fused in register to 17 residues from gp41 containing the pocket for the WWI epitope. 25 All four -peptides, WWI-1-4 Flu , bound IZN17 well, with equilibrium affinities of 0.75 ( 0.1, 1.0 ( 0.3, 2.4 ( 0.7, and 1.5 ( 0.4 µM, respectively ( Figure 2B ). Interestingly, in this case, IZN17 affinity is relatively insensitive to the orientation of the WWI epitope relative to either the 14-helix macrodipole or the salt-bridging face. 14 The affinity of WWI-1-4 for IZN17 is nearly identical to that of the highest affinity R-peptide of comparable size (K d ) 1.2 µM). 10 Also, WWI-1 binds IZN17 with significantly higher affinity than it binds carbonic anhydrase II (K d g 115 µM) or calmodulin (K d > 100 µM), two globular proteins that recognize hydrophobic and/or helical molecules. 19 Two experiments were performed to investigate the binding mode of WWI-1-4. First we performed competition fluorescence polarization experiments to assess whether WWI-1-4 competed with C14wt Flu (suc-MTWMEWDREINNYTC Flu ), a fluorescent analogue of a gp41 ligand 10 27 These data suggest that the affinity of WWI-1-4 for IZN17 results from interactions between the WWI epitope and the targeted IZN17 pocket.
WWI-1-4 were then evaluated for their ability to inhibit gp41-mediated cell-cell fusion in an assay that accurately predicts potency in HIV infectivity assays. 9 HeLa cells that express CD4 and a tat inducible -gal gene 28 were co-cultured in the presence of varying concentrations of -peptides with HXB2 Env-expressing CHO cells 29 that express HIV-1 enV, tat, and reV. Without inhibitors, these cells fuse and form syncytia that express -galactosidase and can be detected with 5-bromo-4-chloro-3-indoyl--D-galactoside. 28 -Peptides WWI-1-4 inhibited cell-cell fusion with EC 50 values of 27 ( 2.5, 15 ( 1.6, 13 ( 1.9, and 5.3 ( 0.5 µM, respectively, whereas WAI-1 was inactive ( Figure 2D ). 19 The EC 50 values measured for WWI-1-4 are equal if not better than those measured for L-peptides, 10 cyclic D-peptides, 9 aromatic foldamers, 11 or small molecules. 13 Although less potent than Fuzeon (IC 50 ) 0.11 nM), 1 WWI-1-4 are one-third the size, likely metabolically stable, 15 and can be optimized combinatorially. These results suggest that molecules such as WWI-1-4 could represent leads toward inhibitors or antigens effective against HIV or other viruses, such as SARS, 30 Ebola, HRSV, and influenza, 31 that employ common fusion mechanisms.
